ezogabine has been researched along with Amyotrophic Lateral Sclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Franssen, H; Groeneveld, GJ; Heuberger, JAAC; Kovalchuk, MO; Sleutjes, BTHM; Stikvoort García, DJL; van den Berg, LH | 1 |
| Ito, D; Morimoto, S; Nakahara, J; Okada, K; Okano, H; Takahashi, S | 1 |
| Kato, C; Morimoto, S; Nakahara, J; Okano, H; Takahashi, S | 1 |
| Atassi, N; Baloh, RH; Bedlack, R; Berry, JD; Camprodon, JA; Celnik, PA; Chaudhry, V; Cudkowicz, ME; David, WS; Davila-Perez, P; Eggan, K; Evora, A; Gable, K; Goutman, SA; Goyal, NA; Hall, M; Hurtado, A; Juel, VC; Kassis, SB; Kaur, D; Kiernan, MC; Kiskinis, E; Klements, D; Koh, J; La, T; Ladha, SS; Lange, DJ; Lewis, RA; Macklin, EA; Maragakis, NJ; Marei, A; Mauricio, EA; McIlduff, CE; Meehan, S; Oskarsson, B; Paganoni, S; Pascual-Leone, A; Pereira, JD; Phielipp, N; Pothier, L; Rivner, MH; Rosenquist, P; Rutkove, SB; Shefner, JM; Simmons, Z; Vucic, S; Wainger, BJ; Weiss, MD; Woolf, CJ | 1 |
| Ferguson, TA; Franssen, H; Groeneveld, GJ; Heuberger, JAAC; Kovalchuk, MO; Sleutjes, BTHM; van den Berg, LH; Ziagkos, D | 1 |
| Eggan, K; Gardner, JP; McNeish, J; Wainger, BJ; Woolf, CJ | 1 |
1 review(s) available for ezogabine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Drug Evaluation, Preclinical; Humans; Induced Pluripotent Stem Cells; Neurodegenerative Diseases; Randomized Controlled Trials as Topic; Translational Research, Biomedical | 2023 |
3 trial(s) available for ezogabine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Drug Evaluation, Preclinical; Induced Pluripotent Stem Cells; Neurodegenerative Diseases; Reproducibility of Results | 2023 |
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Topics: Aged; Amyotrophic Lateral Sclerosis; Anticonvulsants; Carbamates; Cerebral Cortex; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Motor Neurons; Phenylenediamines; Spinal Cord; Treatment Outcome | 2021 |
Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Axons; Carbamates; Cross-Over Studies; Double-Blind Method; Electromyography; Evoked Potentials, Motor; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Motor Neurons; Netherlands; Neuroprotective Agents; Phenylenediamines; Refractory Period, Electrophysiological; Riluzole; Time Factors; Treatment Outcome | 2018 |
2 other study(ies) available for ezogabine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Acute retigabine-induced effects on myelinated motor axons in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Axons; Carbamates; Humans; Motor Neurons; Phenylenediamines | 2022 |
From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial.
Topics: Amyotrophic Lateral Sclerosis; Animals; Carbamates; Clinical Trials as Topic; Drug Discovery; Humans; Induced Pluripotent Stem Cells; Mice; Models, Neurological; Motor Neurons; Mutation; Phenylenediamines; Superoxide Dismutase; Superoxide Dismutase-1; Translational Research, Biomedical | 2015 |